JP2022533645A5 - - Google Patents
Info
- Publication number
- JP2022533645A5 JP2022533645A5 JP2021568543A JP2021568543A JP2022533645A5 JP 2022533645 A5 JP2022533645 A5 JP 2022533645A5 JP 2021568543 A JP2021568543 A JP 2021568543A JP 2021568543 A JP2021568543 A JP 2021568543A JP 2022533645 A5 JP2022533645 A5 JP 2022533645A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- cells
- glycoside hydrolase
- gene therapy
- transgene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962849794P | 2019-05-17 | 2019-05-17 | |
| US62/849,794 | 2019-05-17 | ||
| PCT/US2020/028207 WO2020236351A1 (en) | 2019-05-17 | 2020-04-15 | Improved delivery of gene therapy vectors to retinal cells using a glycoside hydrolase enzyme |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022533645A JP2022533645A (ja) | 2022-07-25 |
| JP2022533645A5 true JP2022533645A5 (cg-RX-API-DMAC7.html) | 2023-04-24 |
Family
ID=70482910
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021568813A Active JP7707081B2 (ja) | 2019-05-17 | 2020-04-15 | 網膜細胞を標的とした最適化された遺伝子治療 |
| JP2021568543A Pending JP2022533645A (ja) | 2019-05-17 | 2020-04-15 | グリコシドヒドロラーゼ酵素を使用する網膜細胞への遺伝子治療ベクターの送達の改善 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021568813A Active JP7707081B2 (ja) | 2019-05-17 | 2020-04-15 | 網膜細胞を標的とした最適化された遺伝子治療 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20220226507A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3969059A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7707081B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220009427A (cg-RX-API-DMAC7.html) |
| CN (1) | CN114126667A (cg-RX-API-DMAC7.html) |
| AR (1) | AR118696A1 (cg-RX-API-DMAC7.html) |
| AU (2) | AU2020278960A1 (cg-RX-API-DMAC7.html) |
| CA (2) | CA3141020A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW202110486A (cg-RX-API-DMAC7.html) |
| WO (2) | WO2020236351A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020154535A1 (en) | 2019-01-23 | 2020-07-30 | University Of Florida Research Foundation, Incorporated | Highly efficient transduction and lateral spread in the retina by a novel aav virus enhanced by rational design |
| US12019249B2 (en) * | 2019-12-25 | 2024-06-25 | Lumus Ltd. | Optical systems and methods for eye tracking based on redirecting light from eye using an optical arrangement associated with a light-guide optical element |
| CN114516901B (zh) * | 2022-03-11 | 2023-01-17 | 上海勉亦生物科技有限公司 | 一种神经系统高亲和性的aav载体及其应用 |
| CN115323001B (zh) * | 2022-07-28 | 2024-11-26 | 深圳先进技术研究院 | 一种靶向视网膜的基因递送系统及其应用 |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
| EP0733103B1 (en) | 1993-11-09 | 2004-03-03 | Targeted Genetics Corporation | Generation of high titers of recombinant aav vectors |
| DE69433922T2 (de) | 1993-11-09 | 2005-07-28 | Medical College Of Ohio, Toledo | Stabile zellinie, die in der lage ist, das replikationsgen des adenoassoziertenvirus zu exprimieren |
| US5658785A (en) | 1994-06-06 | 1997-08-19 | Children's Hospital, Inc. | Adeno-associated virus materials and methods |
| US5856152A (en) | 1994-10-28 | 1999-01-05 | The Trustees Of The University Of Pennsylvania | Hybrid adenovirus-AAV vector and methods of use therefor |
| WO1996017947A1 (en) | 1994-12-06 | 1996-06-13 | Targeted Genetics Corporation | Packaging cell lines for generation of high titers of recombinant aav vectors |
| FR2737730B1 (fr) | 1995-08-10 | 1997-09-05 | Pasteur Merieux Serums Vacc | Procede de purification de virus par chromatographie |
| JPH11511326A (ja) | 1995-08-30 | 1999-10-05 | ジエンザイム コーポレイション | アデノウィルスおよびaavの精製 |
| JPH11514853A (ja) | 1995-09-08 | 1999-12-21 | ジエンザイム コーポレイション | 遺伝子治療のための改良されたaavベクター |
| US5910434A (en) | 1995-12-15 | 1999-06-08 | Systemix, Inc. | Method for obtaining retroviral packaging cell lines producing high transducing efficiency retroviral supernatant |
| EP1696036B1 (en) | 1996-09-06 | 2010-04-21 | The Trustees of The University of Pennsylvania | Use of recombinant adeno-associated virus in the manufacture of a medicament for gene therapy via muscle cells |
| US6566118B1 (en) | 1997-09-05 | 2003-05-20 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| CA2995542A1 (en) | 1997-09-05 | 1999-03-11 | Genzyme Corporation | Methods for generating high titer helper-free preparations of recombinant aav vectors |
| US6258595B1 (en) | 1999-03-18 | 2001-07-10 | The Trustees Of The University Of Pennsylvania | Compositions and methods for helper-free production of recombinant adeno-associated viruses |
| JP2004514407A (ja) | 2000-04-28 | 2004-05-20 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | 異種キャプシド中にシュードタイピングされたaav5キャプシドおよびaav5ベクターを含む組換えaavベクター |
| US9441244B2 (en) | 2003-06-30 | 2016-09-13 | The Regents Of The University Of California | Mutant adeno-associated virus virions and methods of use thereof |
| US9233131B2 (en) | 2003-06-30 | 2016-01-12 | The Regents Of The University Of California | Mutant adeno-associated virus virions and methods of use thereof |
| WO2012109214A1 (en) * | 2011-02-07 | 2012-08-16 | The University Of North Carolina At Chapel Hill | Targeted transduction of aav vectors |
| CN103502458B (zh) * | 2011-02-17 | 2016-11-16 | 宾夕法尼亚大学托管会 | 用于改变组织特异性和改善aav9-介导的基因转移的组合物和方法 |
| US9434928B2 (en) | 2011-11-23 | 2016-09-06 | Nationwide Children's Hospital, Inc. | Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotides |
| DE102012007232B4 (de) | 2012-04-07 | 2014-03-13 | Susanne Weller | Verfahren zur Herstellung von rotierenden elektrischen Maschinen |
| CA2880653C (en) | 2012-08-01 | 2022-05-17 | Nationwide Children's Hospital | Intrathecal delivery of recombinant adeno-associated virus 9 |
| AU2014243925B2 (en) * | 2013-03-14 | 2018-12-06 | Wayne State University | Method of enhancing delivery of therapeutic compounds to the eye |
| JP2015092462A (ja) | 2013-09-30 | 2015-05-14 | Tdk株式会社 | 正極及びそれを用いたリチウムイオン二次電池 |
| WO2015126972A1 (en) * | 2014-02-21 | 2015-08-27 | University Of Florida Research Foundation, Inc. | Methods and compositions for gene delivery to on bipolar cells |
| GB201403260D0 (en) * | 2014-02-25 | 2014-04-09 | Univ Manchester | Treatment of retinal degeneration using gene therapy |
| WO2015141521A1 (ja) | 2014-03-21 | 2015-09-24 | 株式会社日立国際電気 | 基板処理装置、半導体装置の製造方法及び記録媒体 |
| LT3137497T (lt) * | 2014-05-02 | 2021-07-26 | Genzyme Corporation | Aav vektoriai, skirti tinklainės ir cns genų terapijai |
| JP6197169B2 (ja) | 2014-09-29 | 2017-09-20 | 東芝メモリ株式会社 | 半導体装置の製造方法 |
| JP6754361B2 (ja) | 2014-12-16 | 2020-09-09 | ボード オブ リージェンツ オブ ザ ユニバーシティ オブ ネブラスカ | 若年型バッテン病のための遺伝子療法 |
| JP6684343B2 (ja) * | 2015-05-21 | 2020-04-22 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | ニューロン生存因子の相乗組み合わせ及びその使用 |
| EP4134375A1 (en) | 2015-07-30 | 2023-02-15 | Massachusetts Eye & Ear Infirmary | Ancestral adeno associated virus sequences and uses thereof |
| AU2016341428B2 (en) | 2015-10-23 | 2021-12-02 | University Of Iowa Research Foundation | Methods for treating neurodegenerative diseases using gene therapy to delay disease onset and progression while providing cognitive protection |
| JP2019517274A (ja) | 2016-06-13 | 2019-06-24 | ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒルThe University Of North Carolina At Chapel Hill | 最適化されたcln1遺伝子および発現カセットおよびそれらの使用 |
| EP3516046B1 (en) * | 2016-09-22 | 2022-07-13 | Sorbonne Université | Optogenetically transformed photoreceptor precursor cells for the use in the treatment of retinal degenerative diseases |
| MX2020003945A (es) * | 2017-10-18 | 2020-11-09 | Regenxbio Inc | Tratamiento de enfermedades oculares y cancer de colon metastasico con vegf-trap humano modificado post-traduccionalmente . |
-
2020
- 2020-04-15 JP JP2021568813A patent/JP7707081B2/ja active Active
- 2020-04-15 WO PCT/US2020/028207 patent/WO2020236351A1/en not_active Ceased
- 2020-04-15 CN CN202080051735.0A patent/CN114126667A/zh active Pending
- 2020-04-15 AR ARP200101063A patent/AR118696A1/es unknown
- 2020-04-15 JP JP2021568543A patent/JP2022533645A/ja active Pending
- 2020-04-15 CA CA3141020A patent/CA3141020A1/en active Pending
- 2020-04-15 WO PCT/US2020/028352 patent/WO2020236352A1/en not_active Ceased
- 2020-04-15 US US17/611,982 patent/US20220226507A1/en active Pending
- 2020-04-15 EP EP20723738.9A patent/EP3969059A1/en active Pending
- 2020-04-15 AU AU2020278960A patent/AU2020278960A1/en active Pending
- 2020-04-15 US US17/611,972 patent/US20220233655A1/en not_active Abandoned
- 2020-04-15 KR KR1020217040926A patent/KR20220009427A/ko not_active Withdrawn
- 2020-04-15 AU AU2020278499A patent/AU2020278499A1/en active Pending
- 2020-04-15 TW TW109112715A patent/TW202110486A/zh unknown
- 2020-04-15 EP EP20727414.3A patent/EP3969060A1/en active Pending
- 2020-04-15 CA CA3141017A patent/CA3141017A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7832294B2 (ja) | 網膜およびcns遺伝子治療用aavベクター | |
| US12252470B2 (en) | Lipids and nanoparticle compositions thereof | |
| KR102958677B1 (ko) | 이온화 가능한 지질 및 이의 나노입자 조성물 | |
| EP3795181B1 (en) | Treatment of amd using aav2 variant with aflibercept | |
| JP2021503914A5 (cg-RX-API-DMAC7.html) | ||
| JP2022546597A (ja) | 閉端dnaおよび切断可能脂質を含む脂質ナノ粒子組成物ならびにそれらの使用方法 | |
| CN117642380A (zh) | 阳离子脂质及其组合物 | |
| JP2021511030A5 (cg-RX-API-DMAC7.html) | ||
| JP2023527747A (ja) | 新規脂質及びそれらのナノ粒子組成物 | |
| JP2022533983A5 (cg-RX-API-DMAC7.html) | ||
| JP2025506383A5 (cg-RX-API-DMAC7.html) | ||
| JP2025534371A (ja) | Opa1遺伝子変異に関連付けられる疾患を治療するためのopa1プレメッセンジャーrnaのトランススプライシングによる療法 | |
| TW202110486A (zh) | 使用糖苷水解酶改善基因療法載體向視網膜細胞的遞送 | |
| CN121046460A (zh) | 用于治疗Prom1相关视网膜疾病的新型治疗药物 | |
| JP2022523050A5 (cg-RX-API-DMAC7.html) | ||
| US20240189448A1 (en) | Dna structure for treating ocular pathologies | |
| EP2383286A1 (en) | Methods and compositions for treatment of retinal degenerative diseases | |
| JP2023523211A5 (cg-RX-API-DMAC7.html) | ||
| US20210308169A1 (en) | Methods and compositions for treatment of retinal degenerative diseases | |
| HK40049262A (en) | Treatment of amd using aav2 variant with aflibercept | |
| HK40049262B (en) | Treatment of amd using aav2 variant with aflibercept | |
| CN116033915A (zh) | 用于治疗gm1神经节苷脂贮积症及其它病症的组合物和方法 | |
| Houston et al. | GENETICS/RETINOBLASTOMA ADDENDUM: LATE-BREAKING NEW ARTICLES |